PriceTargets.com logo

Merck & Co., Inc. - MRK Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $117.12
  • Forecasted Upside: 33.27%
  • Number of Analysts: 23
  • Breakdown:
  • 0 Sell Ratings
  • 11 Hold Ratings
  • 9 Buy Ratings
  • 3 Strong Buy Ratings
$87.88 As of 03/25/2025 04:58 PM ET
▼ -4.43 (-4.80%)

This chart shows the closing price for MRK by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Merck & Co., Inc. Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MRK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MRK

Analyst Price Target is $117.12
▲ +33.27% Upside Potential
This price target is based on 23 analysts offering 12 month price targets for Merck & Co., Inc. in the last 3 months. The average price target is $117.12, with a high forecast of $155.00 and a low forecast of $96.00. The average price target represents a 33.27% upside from the last price of $87.88.

This chart shows the closing price for MRK for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 23 contributing investment analysts is to moderate buy stock in Merck & Co., Inc.. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 14 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
10/2/2023
  • 0 strong buy ratings
  • 16 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
12/31/2023
  • 0 strong buy ratings
  • 10 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
3/30/2024
  • 1 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
6/28/2024
  • 3 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
9/26/2024
  • 3 strong buy ratings
  • 10 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
12/25/2024
  • 3 strong buy ratings
  • 9 buy ratings
  • 11 hold ratings
  • 1 sell ratings
Ratings as of
2/23/2025
  • 3 strong buy ratings
  • 9 buy ratings
  • 11 hold ratings
  • 0 sell ratings
Ratings as of
3/25/2025

Latest Recommendations

  • 3 strong buy ratings
  • 9 buy ratings
  • 11 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/18/2025Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$128.00 ➝ $105.00
2/12/2025GuggenheimLower TargetBuy ➝ Buy$122.00 ➝ $115.00
2/10/2025TD SecuritiesDowngradeBuy ➝ Hold$121.00 ➝ $100.00
2/10/2025TD CowenDowngradeBuy ➝ Hold$121.00 ➝ $100.00
2/5/2025Bank of AmericaLower TargetBuy ➝ Buy$118.00 ➝ $112.00
2/5/2025BMO Capital MarketsLower TargetMarket Perform ➝ Market Perform$105.00 ➝ $96.00
2/5/2025CitigroupLower TargetBuy ➝ Buy$125.00 ➝ $115.00
2/5/2025Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$113.00 ➝ $106.00
1/28/2025CitigroupLower TargetBuy ➝ Buy$130.00 ➝ $125.00
1/21/2025Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$123.00 ➝ $113.00
1/13/2025Leerink PartnersLower TargetOutperform ➝ Outperform$136.00 ➝ $119.00
1/8/2025UBS GroupLower TargetBuy ➝ Buy$125.00 ➝ $120.00
1/8/2025Truist FinancialReiterated RatingBuy ➝ Hold$130.00 ➝ $110.00
12/20/2024BMO Capital MarketsDowngradeOutperform ➝ Market Perform$136.00 ➝ $105.00
12/10/2024Bank of AmericaReiterated RatingBuy$121.00
12/4/2024Hsbc Global ResUpgradeHold ➝ Strong-Buy
12/4/2024HSBCUpgradeHold ➝ Buy$130.00
11/15/2024Wolfe ResearchInitiated CoveragePeer Perform
11/11/2024Daiwa AmericaDowngradeStrong-Buy ➝ Hold
11/11/2024Daiwa Capital MarketsDowngradeBuy ➝ Neutral
11/7/2024Truist FinancialLower TargetBuy ➝ Buy$132.00 ➝ $130.00
11/6/2024GuggenheimLower TargetBuy ➝ Buy$137.00 ➝ $130.00
11/1/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$125.00 ➝ $110.00
11/1/2024BMO Capital MarketsLower TargetOutperform ➝ Outperform$150.00 ➝ $136.00
11/1/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$130.00 ➝ $123.00
10/25/2024CitigroupLower TargetBuy ➝ Buy$140.00 ➝ $130.00
10/17/2024Sanford C. BernsteinInitiated CoverageMarket Perform$115.00
10/9/2024UBS GroupLower TargetBuy ➝ Buy$142.00 ➝ $136.00
10/9/2024Truist FinancialLower TargetBuy ➝ Buy$143.00 ➝ $132.00
10/7/2024BarclaysLower TargetOverweight ➝ Overweight$142.00 ➝ $140.00
10/3/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$155.00 ➝ $155.00
9/16/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$155.00 ➝ $155.00
8/29/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$155.00 ➝ $155.00
7/31/2024Wolfe ResearchUpgradeStrong-Buy
7/31/2024BarclaysLower TargetOverweight ➝ Overweight$145.00 ➝ $142.00
7/31/2024Bank of AmericaLower TargetBuy ➝ Buy$150.00 ➝ $145.00
7/31/2024UBS GroupLower TargetBuy ➝ Buy$148.00 ➝ $142.00
7/31/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$140.00 ➝ $125.00
7/30/2024Evercore ISIUpgradeStrong-Buy
7/11/2024Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$132.00 ➝ $134.00
6/18/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$155.00 ➝ $155.00
6/5/2024ArgusUpgradeStrong-Buy
6/4/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$155.00 ➝ $155.00
4/26/2024Truist FinancialBoost TargetBuy ➝ Buy$142.00 ➝ $143.00
4/18/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$135.00
4/8/2024Berenberg BankBoost TargetBuy ➝ Buy$140.00 ➝ $143.00
4/5/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$135.00
3/28/2024Truist FinancialReiterated RatingBuy ➝ Buy$139.00 ➝ $142.00
3/27/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$135.00
3/27/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$130.00 ➝ $135.00
3/11/2024Societe GeneraleDowngradeHold ➝ Sell$104.00
2/29/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$135.00
2/14/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$135.00
2/5/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$135.00
2/2/2024Truist FinancialBoost TargetBuy ➝ Buy$122.00 ➝ $139.00
2/2/2024UBS GroupBoost TargetBuy ➝ Buy$135.00 ➝ $148.00
2/2/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$125.00 ➝ $130.00
2/2/2024BarclaysBoost TargetOverweight ➝ Overweight$135.00 ➝ $145.00
1/23/2024BarclaysBoost TargetOverweight ➝ Overweight$130.00 ➝ $135.00
1/9/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$135.00
1/4/2024TD CowenUpgradeMarket Perform ➝ Outperform$125.00 ➝ $135.00
12/18/2023Cantor FitzgeraldReiterated RatingOverweight
11/29/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$135.00
11/15/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$135.00
11/9/2023Deutsche Bank AktiengesellschaftInitiated CoverageBuy$115.00
10/27/2023Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$115.00 ➝ $118.00
10/27/2023BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$132.00
10/23/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$135.00
10/20/2023UBS GroupUpgradeNeutral ➝ Buy$117.00 ➝ $122.00
10/11/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$116.00 ➝ $115.00
10/6/2023Truist FinancialReiterated RatingBuy ➝ Buy$122.00
10/2/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$135.00
9/5/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$135.00
8/22/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$135.00
8/2/2023Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$109.00 ➝ $116.00
8/2/2023Truist FinancialBoost TargetBuy ➝ Buy$116.00 ➝ $122.00
7/20/2023Truist FinancialLower TargetBuy$118.00 ➝ $116.00
7/18/2023BMO Capital MarketsBoost Target$102.00 ➝ $113.00
7/14/2023HSBCInitiated CoverageHold$123.00
5/1/2023BarclaysBoost Target$128.00 ➝ $130.00
4/16/2023BTIG ResearchDowngradeBuy ➝ Neutral
4/13/2023CitigroupUpgradeNeutral ➝ Buy$105.00 ➝ $130.00
4/11/2023GuggenheimBoost TargetBuy$123.00 ➝ $124.00
4/10/2023MizuhoReiterated RatingBuy$130.00
3/28/2023Societe GeneraleDowngradeBuy ➝ Hold
3/17/2023MizuhoReiterated RatingBuy$130.00
3/13/2023Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$120.00 ➝ $115.00
3/10/2023Berenberg BankBoost TargetBuy$125.00 ➝ $130.00
3/9/2023GuggenheimBoost Target$116.00 ➝ $123.00
3/7/2023Atlantic SecuritiesBoost TargetOverweight$122.00 ➝ $127.00
3/7/2023Credit Suisse GroupBoost TargetOutperform$125.00 ➝ $126.00
3/7/2023MizuhoInitiated CoverageBuy$130.00
3/6/2023Jefferies Financial GroupInitiated CoverageBuy$125.00
2/23/2023JPMorgan Chase & Co.Boost TargetOverweight$120.00 ➝ $125.00
2/22/2023Wolfe ResearchUpgradePeer Perform ➝ Outperform$127.00
2/13/2023Credit Suisse GroupBoost TargetOutperform$120.00 ➝ $125.00
2/3/2023Wells Fargo & CompanyLower TargetOverweight$125.00 ➝ $120.00
2/3/2023Morgan StanleyLower TargetEqual Weight$100.00 ➝ $99.00
2/3/2023Leerink PartnersBoost TargetOutperform$120.00 ➝ $122.00
2/3/2023Truist FinancialBoost TargetBuy$106.00 ➝ $118.00
1/23/2023Leerink PartnersBoost TargetOutperform$112.00 ➝ $120.00
1/4/2023Bank of AmericaUpgradeNeutral ➝ Buy$110.00 ➝ $130.00
1/3/2023Wells Fargo & CompanyBoost TargetOverweight$110.00 ➝ $125.00
1/3/2023CowenBoost Target$108.00 ➝ $120.00
12/20/2022BarclaysBoost Target$110.00 ➝ $128.00
12/19/2022Cantor FitzgeraldBoost TargetOverweight$120.00 ➝ $135.00
12/15/2022MizuhoBoost Target$100.00 ➝ $130.00
11/17/2022Credit Suisse GroupInitiated CoverageOutperform$120.00
11/15/2022CitigroupBoost Target$105.00
11/1/2022GuggenheimBoost TargetBuy$104.00 ➝ $111.00
10/28/2022BarclaysBoost TargetOverweight$105.00 ➝ $110.00
10/28/2022Wells Fargo & CompanyBoost TargetOverweight$105.00 ➝ $110.00
10/28/2022Truist FinancialBoost TargetBuy$103.00 ➝ $106.00
10/28/2022Leerink PartnersBoost TargetOutperform$110.00 ➝ $112.00
10/28/2022Morgan StanleyBoost TargetEqual Weight$91.00 ➝ $100.00
10/28/2022Cantor FitzgeraldBoost Target$107.00 ➝ $120.00
10/28/2022Atlantic SecuritiesBoost TargetOverweight$116.00 ➝ $122.00
10/12/2022Morgan StanleyLower TargetEqual Weight$92.00 ➝ $91.00
10/12/2022BarclaysBoost Target$101.00 ➝ $105.00
10/11/2022Atlantic SecuritiesBoost TargetOverweight$110.00 ➝ $116.00
10/11/2022Truist FinancialBoost Target$95.00 ➝ $103.00
10/10/2022GuggenheimUpgradeNeutral ➝ Buy$104.00
9/30/2022Leerink PartnersBoost TargetOutperform$109.00 ➝ $110.00
9/14/2022Berenberg BankUpgradeHold ➝ Buy$95.00 ➝ $100.00
9/12/2022Leerink PartnersBoost TargetOutperform$105.00 ➝ $109.00
8/25/2022Erste Group BankUpgradeHold ➝ Buy
7/29/2022Morgan StanleyBoost TargetEqual Weight$88.00 ➝ $92.00
7/18/2022UBS GroupBoost TargetNeutral$76.00 ➝ $98.00
7/13/2022Atlantic SecuritiesBoost TargetOverweight$105.00 ➝ $110.00
7/8/2022Morgan StanleyBoost TargetEqual Weight$87.00 ➝ $88.00
7/6/2022Daiwa Capital MarketsUpgradeNeutral ➝ Buy$89.00 ➝ $102.00
6/27/2022CowenBoost TargetMarket Perform$95.00 ➝ $102.00
6/27/2022CowenBoost TargetMarket Perform$95.00 ➝ $102.00
6/24/2022MizuhoInitiated CoverageBuy$100.00
6/6/2022Leerink PartnersReiterated RatingOutperform$102.00
4/21/2022Leerink PartnersLower TargetOutperform$100.00 ➝ $97.00
4/12/2022BarclaysBoost TargetOverweight$94.00 ➝ $97.00
4/6/2022Morgan StanleyLower TargetEqual Weight$82.00 ➝ $80.00
4/6/2022Leerink PartnersLower TargetOutperform$101.00 ➝ $100.00
4/1/2022MizuhoInitiated CoverageBuy$100.00
2/4/2022Leerink PartnersLower TargetOutperform$102.00 ➝ $101.00
1/28/2022JPMorgan Chase & Co.Lower TargetOverweight$100.00 ➝ $95.00
12/23/2021MizuhoInitiated CoverageBuy$100.00
12/17/2021The Goldman Sachs GroupInitiated CoverageConviction-Buy$93.00
12/16/2021Daiwa Capital MarketsInitiated CoverageNeutral$70.00
12/13/2021MizuhoReiterated RatingBuy
12/13/2021UBS GroupDowngradeBuy ➝ Neutral$98.00 ➝ $76.00
12/8/2021Wells Fargo & CompanyInitiated CoverageOverweight$90.00
12/7/2021GuggenheimDowngradeBuy ➝ Neutral$98.00
11/30/2021Leerink PartnersReiterated RatingBuy
11/29/2021Morgan StanleyLower TargetSell ➝ Equal Weight$88.00 ➝ $82.00
11/29/2021CitigroupDowngradeBuy ➝ Neutral$105.00 ➝ $85.00
11/24/2021Truist FinancialBoost TargetBuy$92.00 ➝ $95.00
11/18/2021BMO Capital MarketsInitiated CoverageMarket Perform$91.00
11/1/2021BarclaysBoost TargetOverweight$92.00 ➝ $94.00
11/1/2021ArgusUpgradeHold ➝ Buy$110.00
10/29/2021Morgan StanleyBoost TargetEqual Weight$88.00 ➝ $90.00
10/28/2021MizuhoInitiated CoverageBuy$99.00
10/22/2021Leerink PartnersBoost TargetOutperform$104.00 ➝ $105.00
10/12/2021Morgan StanleyBoost TargetEqual Weight$85.00 ➝ $88.00
10/10/2021Berenberg BankReiterated RatingHold$86.00 ➝ $92.00
10/8/2021BarclaysBoost TargetOverweight$87.00 ➝ $92.00
10/4/2021Leerink PartnersBoost TargetOutperform$101.00 ➝ $104.00
10/1/2021MizuhoInitiated CoverageBuy$100.00
9/7/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$90.00 ➝ $85.00
7/30/2021Leerink PartnersBoost TargetOutperform$99.00 ➝ $101.00
7/27/2021Truist FinancialInitiated CoverageBuy$76.79
6/9/2021JPMorgan Chase & Co.Lower TargetOverweight$105.00 ➝ $100.00
6/7/2021Truist FinancialLower TargetBuy$96.00 ➝ $93.00
6/3/2021Leerink PartnersLower TargetOutperform$102.00 ➝ $99.00
5/20/2021ArgusReiterated RatingBuy ➝ Hold
4/30/2021Leerink PartnersLower TargetOutperform$103.00 ➝ $102.00
2/5/2021Cantor FitzgeraldReiterated RatingOverweight
12/6/2020MizuhoReiterated RatingBuy$100.00
11/10/2020Sanford C. BernsteinReiterated RatingOutperform$95.00
11/4/2020JPMorgan Chase & Co.Set TargetNeutral€130.00
10/30/2020The Goldman Sachs GroupSet TargetSell€102.00
10/29/2020Leerink PartnersBoost TargetOutperform$100.00 ➝ $103.00
10/28/2020Kepler Capital MarketsSet TargetBuy€144.00
10/27/2020JPMorgan Chase & Co.Set TargetNeutral€130.00
10/23/2020Truist FinancialInitiated CoverageBuy$96.00
10/21/2020Morgan StanleySet TargetNeutral€127.00
10/21/2020Sanford C. BernsteinSet TargetNeutral€135.00
10/16/2020JPMorgan Chase & Co.Boost TargetOverweight$98.00 ➝ $105.00
10/13/2020BarclaysSet TargetNeutral€125.00
10/1/2020Independent ResearchSet TargetBuy€139.00
9/29/2020Berenberg BankInitiated CoverageHold$88.00
9/28/2020DZ BankReiterated RatingBuy
9/28/2020The Goldman Sachs GroupSet TargetSell€102.00
9/22/2020MizuhoReiterated RatingBuy
9/22/2020The Goldman Sachs GroupSet TargetSell€100.00
9/21/2020JPMorgan Chase & Co.Set TargetNeutral€130.00
9/18/2020Independent ResearchSet TargetBuy€138.00
9/17/2020Credit Suisse GroupSet TargetBuy€140.00
9/16/2020Sanford C. BernsteinSet TargetNeutral€115.00
9/16/2020The Goldman Sachs GroupSet TargetSell€100.00
9/15/2020JPMorgan Chase & Co.Set TargetNeutral€130.00
9/14/2020Morgan StanleySet TargetNeutral€127.00
8/27/2020Kepler Capital MarketsSet TargetBuy€130.00
8/25/2020Leerink PartnersBoost TargetOutperform$95.00 ➝ $100.00
8/24/2020The Goldman Sachs GroupSet TargetSell€100.00
8/10/2020DZ BankReiterated RatingBuy
8/7/2020Independent ResearchSet TargetBuy€124.00
8/7/2020Kepler Capital MarketsSet TargetBuy€130.00
8/7/2020UBS GroupSet TargetNeutral€108.00
8/7/2020Sanford C. BernsteinSet TargetNeutral€115.00
8/7/2020Credit Suisse GroupSet TargetBuy€125.00
8/7/2020BarclaysSet TargetSell€92.00
8/6/2020Warburg ResearchSet TargetNeutral€108.00
8/6/2020Nord/LBSet TargetNeutral€108.00
8/6/2020Deutsche Bank AktiengesellschaftSet TargetNeutral€110.00
8/6/2020The Goldman Sachs GroupSet TargetSell€94.00
8/6/2020JPMorgan Chase & Co.Set TargetNeutral€110.00
8/4/2020Royal Bank of CanadaReiterated RatingHold
8/3/2020The Goldman Sachs GroupUpgradeNeutral ➝ Buy$91.00 ➝ $105.00
7/31/2020MizuhoReiterated RatingBuy$100.00
7/29/2020Warburg ResearchSet TargetNeutral€108.00
7/29/2020JPMorgan Chase & Co.Set TargetNeutral€110.00
7/28/2020The Goldman Sachs GroupSet TargetSell€94.00
7/23/2020JPMorgan Chase & Co.Set TargetNeutral€110.00
7/22/2020DZ BankReiterated RatingBuy
7/22/2020Credit Suisse GroupSet TargetBuy€125.00
7/21/2020The Goldman Sachs GroupSet TargetSell€94.00
7/7/2020JPMorgan Chase & Co.Set TargetNeutral€110.00
7/1/2020Kepler Capital MarketsSet TargetSell€122.00
6/23/2020MizuhoReiterated RatingBuy$100.00
6/23/2020Morgan StanleyReiterated RatingBuy$89.00
6/12/2020Wolfe ResearchDowngradeOutperform ➝ Peer Perform
6/10/2020Kepler Capital MarketsSet TargetBuy€122.00
6/10/2020The Goldman Sachs GroupSet TargetSell€94.00
6/8/2020Sanford C. BernsteinSet TargetNeutral€115.00
6/4/2020JPMorgan Chase & Co.Set TargetNeutral€110.00
6/3/2020BarclaysSet TargetSell€90.00
6/2/2020The Goldman Sachs GroupSet TargetSell€94.00
5/29/2020JPMorgan Chase & Co.Set TargetNeutral€110.00
5/27/2020The Goldman Sachs GroupSet TargetSell€94.00
5/21/2020Deutsche Bank AktiengesellschaftSet TargetNeutral€110.00
5/19/2020DZ BankReiterated RatingBuy
5/18/2020HSBCSet TargetNeutral€101.00
5/15/2020BarclaysSet TargetSell€90.00
5/15/2020Deutsche Bank AktiengesellschaftSet TargetNeutral€110.00
5/15/2020Credit Suisse GroupSet TargetBuy€125.00
5/15/2020Independent ResearchSet TargetBuy€122.00
5/15/2020Nord/LBSet TargetNeutral€110.00
5/14/2020Sanford C. BernsteinSet TargetNeutral€113.00
5/14/2020JPMorgan Chase & Co.Set TargetNeutral€110.00
5/14/2020UBS GroupSet TargetNeutral€108.00
5/14/2020The Goldman Sachs GroupSet TargetSell€94.00
5/14/2020Warburg ResearchSet TargetNeutral€106.00
5/7/2020Warburg ResearchSet TargetNeutral€106.00
5/5/2020Kepler Capital MarketsSet TargetBuy€122.00
5/5/2020BarclaysSet TargetSell€90.00
5/5/2020Deutsche Bank AktiengesellschaftSet TargetNeutral€110.00
5/5/2020The Goldman Sachs GroupSet TargetSell€94.00
5/5/2020Credit Suisse GroupSet TargetBuy€125.00
5/4/2020DZ BankReiterated RatingBuy
5/4/2020Credit Suisse GroupReiterated RatingBuy$95.00
5/1/2020JPMorgan Chase & Co.Set TargetNeutral€110.00
4/29/2020GuggenheimLower TargetBuy$101.00 ➝ $93.00
4/29/2020BarclaysLower TargetOverweight$93.00 ➝ $90.00
4/29/2020Leerink PartnersLower TargetOutperform$98.00 ➝ $95.00
4/16/2020The Goldman Sachs GroupSet TargetSell€94.00
4/15/2020Sanford C. BernsteinSet TargetNeutral€113.00
4/13/2020UBS GroupLower TargetBuy$96.00 ➝ $92.00
4/7/2020The Goldman Sachs GroupSet TargetSell€94.00
4/2/2020Morgan StanleyLower TargetOverweight$97.00 ➝ $89.00
4/1/2020Royal Bank of CanadaLower TargetSector Perform$92.00 ➝ $89.00
(Data available from 3/25/2020 forward)

News Sentiment Rating

1.19 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 35 very positive mentions
  • 37 positive mentions
  • 6 negative mentions
  • 1 very negative mentions
Mentions as of
8/27/2024
  • 44 very positive mentions
  • 29 positive mentions
  • 7 negative mentions
  • 2 very negative mentions
Mentions as of
9/26/2024
  • 43 very positive mentions
  • 42 positive mentions
  • 8 negative mentions
  • 0 very negative mentions
Mentions as of
10/26/2024
  • 153 very positive mentions
  • 52 positive mentions
  • 11 negative mentions
  • 3 very negative mentions
Mentions as of
11/25/2024
  • 150 very positive mentions
  • 52 positive mentions
  • 5 negative mentions
  • 2 very negative mentions
Mentions as of
12/25/2024
  • 139 very positive mentions
  • 28 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Mentions as of
1/24/2025
  • 316 very positive mentions
  • 98 positive mentions
  • 23 negative mentions
  • 7 very negative mentions
Mentions as of
2/23/2025
  • 313 very positive mentions
  • 130 positive mentions
  • 10 negative mentions
  • 1 very negative mentions
Mentions as of
3/25/2025

Current Sentiment

  • 313 very positive mentions
  • 130 positive mentions
  • 10 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Merck & Co., Inc. logo
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Read More

Today's Range

Now: $87.88
Low: $87.08
High: $92.31

50 Day Range

MA: $92.60
Low: $83.01
High: $100.72

52 Week Range

Now: $87.88
Low: $81.04
High: $134.63

Volume

20,632,114 shs

Average Volume

10,295,041 shs

Market Capitalization

$221.99 billion

P/E Ratio

13.06

Dividend Yield

3.42%

Beta

0.35

Frequently Asked Questions

What sell-side analysts currently cover shares of Merck & Co., Inc.?

The following Wall Street research analysts have issued research reports on Merck & Co., Inc. in the last twelve months: Argus, Bank of America Co., Barclays PLC, Berenberg Bank, BMO Capital Markets, Cantor Fitzgerald, Citigroup Inc., Daiwa America, Daiwa Capital Markets, Deutsche Bank Aktiengesellschaft, Evercore ISI, Guggenheim, Hsbc Global Res, HSBC Holdings plc, Leerink Partners, Morgan Stanley, Sanford C. Bernstein, TD Cowen, TD Securities, Truist Financial Co., UBS Group AG, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for MRK.

What is the current price target for Merck & Co., Inc.?

0 Wall Street analysts have set twelve-month price targets for Merck & Co., Inc. in the last year. Their average twelve-month price target is $117.12, suggesting a possible upside of 33.3%. Cantor Fitzgerald has the highest price target set, predicting MRK will reach $155.00 in the next twelve months. BMO Capital Markets has the lowest price target set, forecasting a price of $96.00 for Merck & Co., Inc. in the next year.
View the latest price targets for MRK.

What is the current consensus analyst rating for Merck & Co., Inc.?

Merck & Co., Inc. currently has 11 hold ratings, 9 buy ratings and 3 strong buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for MRK.

What other companies compete with Merck & Co., Inc.?

Other companies that are similar to Merck & Co., Inc. include Eli Lilly and Company, Johnson & Johnson, AbbVie, Pfizer and Bristol-Myers Squibb. Learn More about companies similar to Merck & Co., Inc..

How do I contact Merck & Co., Inc.'s investor relations team?

Merck & Co., Inc.'s physical mailing address is 2000 GALLOPING HILL ROAD, KENILWORTH NJ, 07033. The company's listed phone number is (908) 740-4000 and its investor relations email address is [email protected]. The official website for Merck & Co., Inc. is www.merck.com. Learn More about contacing Merck & Co., Inc. investor relations.